Fasting is not always good: perioperative fasting leads to pronounced ketone body production in patients treated with SGLT2 inhibitors: a case report
- Author:
Jae Chan CHOI
1
;
Yo Nam JANG
;
Jong Hoon LEE
;
Sang Wook PARK
;
Jeong A PARK
;
Hye Sook KIM
;
Jae Won CHOI
;
Joo Hyung LEE
;
Yong Jae LEE
Author Information
- Publication Type:Case Report
- From:Korean Journal of Family Medicine 2025;46(3):204-209
- CountryRepublic of Korea
- Language:English
- Abstract: Ketone bodies produced by sodium-glucose cotransporter 2 (SGLT2) inhibitors can be advantageous, providing an efficient and stable energy source for the brain and muscles. However, in patients with diabetes, ketogenesis induced by SGLT2 inhibitors may be harmful, potentially resulting in severe diabetic ketoacidosis (DKA). During fasting, ketone body production serves as an alternative and efficient energy source for the brain by utilizing stored fat, promoting mental clarity, and reducing dependence on glucose. The concurrent use of SGLT2 inhibitors during perioperative fasting may further elevate the risk of euglycemic DKA. We describe a case of DKA that occurred during perioperative fasting in a patient receiving empagliflozin, an SGLT2 inhibitor. This case underscores the importance of recognizing the potential risk of DKA in patients with diabetes using SGLT2 inhibitors during perioperative fasting.
